---
figid: PMC4925727__WO-20-26262-g003
figtitle: Tyrosine kinase receptors and their signalling pathways involved in angiogenesis
organisms:
- NA
pmcid: PMC4925727
filename: WO-20-26262-g003.jpg
figlink: /pmc/articles/PMC4925727/figure/F0003/
number: F3
caption: Tyrosine kinase receptors and their signalling pathways involved in angiogenesis.
  Wnt catenin pathway stimulates tyrosine kinase receptors (TKRs) activation. RAS/RAF/ERK/MAPK
  and PI3K/Akt signalling pathways activation can produce a variety of processes involved
  in angiogenesis like cell proliferation, migration and survival. eNos (endothelial
  nitric oxide synthase) influenced by AKT/PKB promotes vascular permeability. MEK
  stimulates PTEN (phosphatase and tensin homolog) inhibiting protein kinase B (PKB).
  BAD (Bcl-2-associated death promoter); Potential therapeutic targets are specified
papertitle: New perspectives in glioblastoma antiangiogenic therapy.
reftext: Alisa Madalina Popescu, et al. Contemp Oncol (Pozn). 2016;20(2):109-118.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9268517
figid_alias: PMC4925727__F3
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC4925727__F3
ndex: 69100325-df0c-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4925727__WO-20-26262-g003.html
  '@type': Dataset
  description: Tyrosine kinase receptors and their signalling pathways involved in
    angiogenesis. Wnt catenin pathway stimulates tyrosine kinase receptors (TKRs)
    activation. RAS/RAF/ERK/MAPK and PI3K/Akt signalling pathways activation can produce
    a variety of processes involved in angiogenesis like cell proliferation, migration
    and survival. eNos (endothelial nitric oxide synthase) influenced by AKT/PKB promotes
    vascular permeability. MEK stimulates PTEN (phosphatase and tensin homolog) inhibiting
    protein kinase B (PKB). BAD (Bcl-2-associated death promoter); Potential therapeutic
    targets are specified
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - btl
  - htl
  - Egfr
  - Pvr
  - Wnt5
  - Wnt4
  - wg
  - Wnt2
  - drk
  - Sos
  - Gapdh2
  - CdGAPr
  - Gapdh1
  - RasGAP1
  - ArfGAP1
  - Src42A
  - Csk
  - Src64B
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - ras
  - Ras64B
  - Ras85D
  - Raf
  - Akt
  - Pten
  - Dsor1
  - Mtk
  - cass
  - arm
  - Mtor
  - Tor
  - MKP-4
  - p38b
  - rl
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - FGFR1
  - FGFR2
  - FGFR3
  - FGFR4
  - FGFRL1
  - EGFR
  - KDR
  - FLT1
  - FLT4
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - GRB2
  - A1BG
  - XYLT2
  - SOS1
  - SOS2
  - RASA1
  - RGS6
  - SRC
  - FGR
  - FYN
  - YES1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - AKT1
  - AKT2
  - AKT3
  - PTK2B
  - PTEN
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - BAD
  - CTNNB1
  - MTOR
  - NOS3
  - ENO4
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - Tyrosine
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
